Andrzej Mackiewicz
Overview
Explore the profile of Andrzej Mackiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
3907
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szostak N, Budnik M, Tomela K, Handschuh L, Samelak-Czajka A, Pietrzak B, et al.
Cancer Immunol Immunother
. 2025 Feb;
74(4):110.
PMID: 39998665
Research has shown that the microbiome can influence how the immune system responds to melanoma cells, affecting the course of the disease and the outcome of the therapy. Here, we...
2.
Khalaf K, Chamieh M, Welc N, Singh C, Kaouk J, Kaouk A, et al.
Front Immunol
. 2025 Feb;
16:1461535.
PMID: 39944697
Atherosclerosis, previously regarded as a lipid storage disease, has now been classified as a chronic inflammatory disease. The hardening of arterial vessels characterizes atherosclerosis due to the accumulation of lipids...
3.
Kolenda T, Guglas K, Stasiak M, Poter P, Kozlowska-Maslon J, Bialas P, et al.
EXCLI J
. 2025 Jan;
23:1375-1396.
PMID: 39764216
Cutaneous melanoma is the deadliest form of skin cancer. Despite advancements in treatment, many patients still face poor outcomes. A deeper understanding of the mechanisms involved in melanoma pathogenesis is...
4.
Drymel B, Tomela K, Galus L, Olejnik-Schmidt A, Mackiewicz J, Kaczmarek M, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684692
An accumulating number of studies suggest the potential of circulating cell-free microbial DNA (cfmDNA) as a non-invasive biomarker in various diseases, including cancers. However, its value in the prediction or...
5.
Hoffmann-Mlodzianowska M, Maksym R, Pucia K, Kuciak M, Mackiewicz A, Kieda C
Mol Med
. 2024 Oct;
30(1):195.
PMID: 39478503
Background: Endometriosis, due to its ambiguous symptoms, still remains one of the most difficult female diseases to treat, with an average diagnosis time of 7-9 years. The changing level of...
6.
Kazimierczak U, Przybyla A, Smielowska M, Kolenda T, Mackiewicz A
Cells
. 2024 Jun;
13(12.
PMID: 38920690
Melanoma is the most aggressive form of skin cancer. In the advanced stage of development, it is resistant to currently available therapeutic modalities. Increased invasiveness and metastatic potential depend on...
7.
Szostak N, Handschuh L, Samelak-Czajka A, Tomela K, Pietrzak B, Schmidt M, et al.
Cancer Immunol Res
. 2024 Feb;
12(4):427-439.
PMID: 38315788
Recent research indicates that gut microbiota may be vital in the advancement of melanoma. In this study, we found that melanoma patients exhibited a distinct gut mycobiota structure compared with...
8.
Oleksiewicz U, Machnik M, Sobocinska J, Molenda S, Olechnowicz A, Florczak A, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003570
The global cancer burden remains high; thus, a better understanding of the molecular mechanisms driving carcinogenesis is needed to improve current prevention and treatment options. We previously detected the ZNF643/ZFP69B...
9.
Kaczmarek M, Poznanska J, Fechner F, Michalska N, Paszkowska S, Napierala A, et al.
Cells
. 2023 Sep;
12(17).
PMID: 37681891
In recent years, there has been a surge of interest in tumor microenvironment-associated cancer vaccine therapies. These innovative treatments aim to activate and enhance the body's natural immune response against...
10.
Krzykawska-Serda M, Szczygiel D, Gawel S, Drzal A, Szczygiel M, Kmiec M, et al.
PLoS One
. 2023 May;
18(5):e0285318.
PMID: 37167239
Hypoxia, an inevitable feature of locally advanced solid tumors, has been known as an adverse prognostic factor, a driver of an aggressive phenotype, and an unfavorable factor in therapies. Myo-inositol...